Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $48.9 Million - $66.3 Million
-436,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $33.3 Million - $47.3 Million
311,723 Added 250.83%
436,000 $52 Million
Q4 2018

Feb 14, 2019

BUY
$97.32 - $148.76 $12.1 Million - $18.5 Million
124,277 New
124,277 $13.6 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Highline Capital Management, L.P. Portfolio

Follow Highline Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highline Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highline Capital Management, L.P. with notifications on news.